GSK
GSK plcCompany with tickers: GSK, GLAXF
CIK
1131399
CUSIP
37733W204
Shares Outstanding
2,004,414,458
Website
https://www.gsk.com/
Investor Relations
https://www.gsk.com/investor-relations
13F Activity (30d)
41 filings
30 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2025-10-08 | — | |
| 6-K | 2025-10-09 | — | |
| 6-K | 2025-10-10 | — | |
| 6-K | 2025-10-14 | — | |
| 6-K | 2025-10-15 | — | |
| 6-K | 2025-10-16 | — | |
| 6-K | 2025-10-17 | — | |
| 6-K | 2025-10-20 | — | |
| 6-K | 2025-10-21 | — | |
| 6-K | 2025-10-22 | — | |
| 6-K | 2025-10-23 | — | |
| 6-K | 2025-10-24 | — | |
| 6-K | 2025-10-27 | — | |
| 6-K | 2025-10-28 | — | |
| 6-K | 2025-10-29 | — | |
| 6-K | 2025-10-30 | — | |
| 6-K | 2025-10-31 | — | |
| 6-K | 2025-11-03 | — | |
| 6-K | 2025-11-04 | — | |
| 6-K | 2025-11-05 | — | |
| 6-K | 2025-11-06 | — | |
| 6-K | 2025-11-07 | — | |
| 6-K | 2025-11-10 | — | |
| 6-K | 2025-11-12 | — | |
| 6-K | 2025-11-13 | — | |
| 6-K | 2025-11-14 | — | |
| 6-K | 2025-11-17 | — | |
| 6-K | 2025-11-18 | — | |
| 6-K | 2025-11-19 | — | |
| 6-K | 2025-11-20 | — | |
| 6-K | 2025-11-21 | — | |
| 6-K | 2025-11-24 | — | |
| 6-K | 2025-11-25 | — | |
| 6-K | 2025-11-26 | — | |
| 6-K | 2025-11-28 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-12-02 | — | |
| 6-K | 2025-12-03 | — | |
| 6-K | 2025-12-04 | — | |
| 6-K | 2025-12-05 | — | |
| 6-K | 2025-12-08 | — | |
| 6-K | 2025-12-09 | — | |
| 6-K | 2025-12-10 | — | |
| 6-K | 2025-12-11 | — | |
| 6-K | 2025-12-12 | — | |
| 6-K | 2025-12-15 | — | |
| 6-K | 2025-12-16 | — | |
| 6-K | 2025-12-17 | — | |
| 6-K | 2025-12-18 | — | |
| 6-K | 2025-12-19 | — |
Showing 701–750 of 837 filings